# OnCo record nct07744256 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07744256/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07744256", "NCT07744256" ;
  schema:name "Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)"@en ;
  schema:description "A phase 1/2 trial of EB-DART-NK01 in small-cell lung cancer, run by Beijing Biotech, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07744256/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07744256> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-03-02" ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:targets <https://onco.cc/targets/gd2/>, <https://onco.cc/targets/dll3/> .